Multicenter, prospective, observational study for evaluating if circulant rheumatoid factor, cyclic citrullinated anti-peptide anti-bodies and albumin can be used as potential predictors in the response to the treatment with anti-TNF in patients with rheumatoid arthritis after 24 weeks of treatment.
Study Type
OBSERVATIONAL
Enrollment
200
Hospital San Cecilio
Granada, Andalusia, Spain
NOT_YET_RECRUITINGAnti-TNF treatment response based on circulant rheumatoid factor
Time frame: 24 weeks
Anti-TNF treatment response based on circulant cyclic citrullinated anti-peptide antibodies.
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Carlos Haya
Málaga, Andalusia, Spain
NOT_YET_RECRUITINGHospital Virgen del Rocio
Seville, Andalusia, Spain
NOT_YET_RECRUITINGHospital Son LLatzer
Palma de Mallorca, Balearic Islands, Spain
NOT_YET_RECRUITINGHospital de Basurto
Bilbao, Basque Country, Spain
NOT_YET_RECRUITINGHospital Universitario de Canarias
San Cristóbal de La Laguna, Canary Islands, Spain
NOT_YET_RECRUITINGHospital Marques de Valdecilla
Santander, Cantabria, Spain
NOT_YET_RECRUITINGHospital de Guadalajara
Guadalajara, Castille-La Mancha, Spain
NOT_YET_RECRUITINGHospital Vall d'Hebron
Barcelona, Catalonia, Spain
RECRUITINGClínic de Barcelona
Barcelona, Catalonia, Spain
NOT_YET_RECRUITING...and 9 more locations